메뉴 건너뛰기




Volumn 24, Issue 3, 2011, Pages 279-282

Chelators to the rescue: Different horses for different courses!

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; IRON CHELATOR; IRON DERIVATIVE; N' [1 (2 HYDROXY 5 NITROPHENYL)ETHYLIDEN]ISONICOTINOYLHYDRAZIDE; N' [1 (2 HYDROXYPHENYL)ETHYLIDEN]ISONICOTINOYLHYDRAZIDE; PYRIDOXAL ISONICOTINOYL HYDRAZONE; REACTIVE OXYGEN METABOLITE; SALICYLALDEHYDE ISONICOTINOYL HYDRAZONE; UNCLASSIFIED DRUG;

EID: 79952908217     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx100435c     Document Type: Editorial
Times cited : (9)

References (38)
  • 1
    • 0029758487 scopus 로고    scopus 로고
    • Molecular control of vertebrate iron metabolism: MRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress
    • DOI 10.1073/pnas.93.16.8175
    • Hentze, M. W. and Kuhn, L. C. (1996) Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress Proc. Natl. Acad. Sci. U.S.A. 93, 8175-8182 (Pubitemid 26269529)
    • (1996) Proceedings of the National Academy of Sciences of the United States of America , vol.93 , Issue.16 , pp. 8175-8182
    • Hentze, M.W.1    Kuhn, L.C.2
  • 2
    • 0031567095 scopus 로고    scopus 로고
    • The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells
    • DOI 10.1016/S0304-4157(96)00014-7, PII S0304415796000147
    • Richardson, D. R. and Ponka, P. (1997) The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells Biochim. Biophys. Acta 1331, 1-40 (Pubitemid 27168147)
    • (1997) Biochimica et Biophysica Acta - Reviews on Biomembranes , vol.1331 , Issue.1 , pp. 1-40
    • Richardson, D.R.1    Ponka, P.2
  • 3
    • 31344478802 scopus 로고    scopus 로고
    • The redox couple of the cytochrome c cyanide complex: The contribution of heme iron ligation to the structural stability, chemical reactivity, and physiological behavior of horse cytochrome c
    • DOI 10.1110/ps.051825906
    • Schejter, A., Ryan, M. D., Blizzard, E. R., Zhang, C., Margoliash, E., and Feinberg, B. A. (2006) The redox couple of the cytochrome c cyanide complex: The contribution of heme iron ligation to the structural stability, chemical reactivity, and physiological behavior of horse cytochrome c Protein Sci. 15, 234-241 (Pubitemid 43144995)
    • (2006) Protein Science , vol.15 , Issue.2 , pp. 234-241
    • Schejter, A.1    Ryan, M.D.2    Blizzard, E.R.3    Zhang, C.4    Margoliash, E.5    Feinberg, B.A.6
  • 4
    • 0015890741 scopus 로고
    • Iron and free radical in ribonucleotide reductase. Exchange of iron and Mossbauer spectroscopy of the protein B2 subunit of the Escherichia coli enzyme
    • Atkin, C. L., Thelander, L., Reichard, P., and Lang, G. (1973) Iron and free radical in ribonucleotide reductase. Exchange of iron and Mossbauer spectroscopy of the protein B2 subunit of the Escherichia coli enzyme J. Biol. Chem. 248, 7464-7472
    • (1973) J. Biol. Chem. , vol.248 , pp. 7464-7472
    • Atkin, C.L.1    Thelander, L.2    Reichard, P.3    Lang, G.4
  • 6
    • 78149246362 scopus 로고    scopus 로고
    • The hazards of iron loading
    • Weinberg, E. D. (2010) The hazards of iron loading Metallomics 2, 732-740
    • (2010) Metallomics , vol.2 , pp. 732-740
    • Weinberg, E.D.1
  • 7
    • 0037411115 scopus 로고    scopus 로고
    • β-Thalassaemia: Emergence of new and improved iron chelators for treatment
    • DOI 10.1016/S1357-2725(03)00046-3
    • Wong, C. and Richardson, D. R. (2003) Beta-thalassaemia: emergence of new and improved iron chelators for treatment Int. J. Biochem. Cell Biol. 35, 1144-1149 (Pubitemid 36369501)
    • (2003) International Journal of Biochemistry and Cell Biology , vol.35 , Issue.7 , pp. 1144-1149
    • Wong, C.1    Richardson, D.R.2
  • 8
    • 0031001278 scopus 로고    scopus 로고
    • Iron-chelating therapy and the treatment of thalassemia
    • Olivieri, N. F. and Brittenham, G. M. (1997) Iron-chelating therapy and the treatment of thalassemia Blood 89, 739-761 (Pubitemid 27121266)
    • (1997) Blood , vol.89 , Issue.3 , pp. 739-761
    • Olivieri, N.F.1    Brittenham, G.M.2
  • 9
    • 14944387002 scopus 로고    scopus 로고
    • Iron trafficking in the mitochondrion: Novel pathways revealed by disease
    • DOI 10.1182/blood-2004-10-3856
    • Napier, I., Ponka, P., and Richardson, D. R. (2005) Iron trafficking in the mitochondrion: novel pathways revealed by disease Blood 105, 1867-1874 (Pubitemid 40731766)
    • (2005) Blood , vol.105 , Issue.5 , pp. 1867-1874
    • Napier, I.1    Ponka, P.2    Richardson, D.R.3
  • 11
    • 29844457587 scopus 로고    scopus 로고
    • The evolution of iron chelators for the treatment of iron overload disease and cancer
    • DOI 10.1124/pr.57.4.2
    • Kalinowski, D. S. and Richardson, D. R. (2005) The evolution of iron chelators for the treatment of iron overload disease and cancer Pharmacol. Rev. 57, 547-583 (Pubitemid 43036441)
    • (2005) Pharmacological Reviews , vol.57 , Issue.4 , pp. 547-583
    • Kalinowski, D.S.1    Richardson, D.R.2
  • 12
    • 0037631496 scopus 로고    scopus 로고
    • Iron chelators for the treatment of iron overload disease: Relationship between structure, redox activity, and toxicity
    • DOI 10.1002/ajh.10348
    • Chaston, T. B. and Richardson, D. R. (2003) Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity Am. J. Hematol. 73, 200-210 (Pubitemid 36753964)
    • (2003) American Journal of Hematology , vol.73 , Issue.3 , pp. 200-210
    • Chaston, T.B.1    Richardson, D.R.2
  • 13
    • 33750716051 scopus 로고    scopus 로고
    • Iron: A New Target for Pharmacological Intervention in Neurodegenerative Diseases
    • DOI 10.1016/j.spen.2006.08.008, PII S1071909106001070
    • Whitnall, M. and Richardson, D. R. (2006) Iron: a new target for pharmacological intervention in neurodegenerative diseases Semin. Pediatr. Neurol. 13, 186-197 (Pubitemid 44709656)
    • (2006) Seminars in Pediatric Neurology , vol.13 , Issue.3 , pp. 186-197
    • Whitnall, M.1    Richardson, D.R.2
  • 16
    • 2442698003 scopus 로고    scopus 로고
    • Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion
    • DOI 10.1200/JCO.2004.07.158
    • Wadler, S., Makower, D., Clairmont, C., Lambert, P., Fehn, K., and Sznol, M. (2004) Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-h intravenous continuous infusion J. Clin. Oncol. 22, 1553-1563 (Pubitemid 41079792)
    • (2004) Journal of Clinical Oncology , vol.22 , Issue.9 , pp. 1553-1563
    • Wadler, S.1    Makower, D.2    Clainmont, C.3    Lambert, P.4    Fehn, K.5    Sznol, M.6
  • 18
    • 8444235919 scopus 로고    scopus 로고
    • Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves fenton-derived free radical generation
    • DOI 10.1158/1078-0432.CCR-04-0865
    • Chaston, T. B., Watts, R. N., Yuan, J., and Richardson, D. R. (2004) Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves fenton-derived free radical generation Clin. Cancer Res. 10, 7365-7374 (Pubitemid 39487726)
    • (2004) Clinical Cancer Research , vol.10 , Issue.21 , pp. 7365-7374
    • Chaston, T.B.1    Watts, R.N.2    Yuan, J.3    Richardson, D.R.4
  • 19
    • 76749092292 scopus 로고    scopus 로고
    • Phase i trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer
    • Kunos, C. A., Waggoner, S., von Gruenigen, V., Eldermire, E., Pink, J., Dowlati, A., and Kinsella, T. J. (2010) Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer Clin. Cancer Res. 16, 1298-1306
    • (2010) Clin. Cancer Res. , vol.16 , pp. 1298-1306
    • Kunos, C.A.1    Waggoner, S.2    Von Gruenigen, V.3    Eldermire, E.4    Pink, J.5    Dowlati, A.6    Kinsella, T.J.7
  • 20
    • 66949171305 scopus 로고    scopus 로고
    • Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
    • Simunek, T., Sterba, M., Popelova, O., Adamcova, M., Hrdina, R., and Gersl, V. (2009) Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron Pharmacol. Rep. 61, 154-171
    • (2009) Pharmacol. Rep. , vol.61 , pp. 154-171
    • Simunek, T.1    Sterba, M.2    Popelova, O.3    Adamcova, M.4    Hrdina, R.5    Gersl, V.6
  • 22
    • 79952917106 scopus 로고    scopus 로고
    • Synthesis and initial in vitro evaluations of novel antioxidant aroylhydrazone iron chelators with increased stability against plasma hydrolysis
    • 10.1021/tx100359t
    • Hruskova, K., Kovarikova, P., Bendova, P., Haskova, P., Mackova, E., Stariat, J., Vavrova, A., Vavrova, K., and Simunek, T. (2011) Synthesis and initial in vitro evaluations of novel antioxidant aroylhydrazone iron chelators with increased stability against plasma hydrolysis Chem. Res. Toxicol. 10.1021/tx100359t
    • (2011) Chem. Res. Toxicol.
    • Hruskova, K.1    Kovarikova, P.2    Bendova, P.3    Haskova, P.4    MacKova, E.5    Stariat, J.6    Vavrova, A.7    Vavrova, K.8    Simunek, T.9
  • 23
    • 77955444881 scopus 로고    scopus 로고
    • Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy
    • Turer, A. T. and Hill, J. A. (2010) Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy Am. J. Cardiol. 106, 1521-1522
    • (2010) Am. J. Cardiol. , vol.106 , pp. 1521-1522
    • Turer, A.T.1    Hill, J.A.2
  • 24
    • 0026538966 scopus 로고
    • Iron chelation in myocardial preservation after ischemia-reperfusion injury: The importance of pretreatment and toxicity
    • DeBoer, D. A. and Clark, R. E. (1992) Iron chelation in myocardial preservation after ischemia-reperfusion injury: the importance of pretreatment and toxicity Ann. Thorac. Surg. 53, 412-418
    • (1992) Ann. Thorac. Surg. , vol.53 , pp. 412-418
    • Deboer, D.A.1    Clark, R.E.2
  • 25
    • 0033067885 scopus 로고    scopus 로고
    • Iron-mediated cardiovascular injury
    • Horwitz, L. D. and Rosenthal, E. A. (1999) Iron-mediated cardiovascular injury Vasc. Med. 4, 93-99 (Pubitemid 29290825)
    • (1999) Vascular Medicine , vol.4 , Issue.2 , pp. 93-99
    • Horwitz, L.D.1    Rosenthal, E.A.2
  • 27
    • 0026007641 scopus 로고
    • Effects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs
    • Maruyama, M., Pieper, G. M., Kalyanaraman, B., Hallaway, P. E., Hedlund, B. E., and Gross, G. J. (1991) Effects of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs J. Cardiovasc. Pharmacol. 17, 166-175
    • (1991) J. Cardiovasc. Pharmacol. , vol.17 , pp. 166-175
    • Maruyama, M.1    Pieper, G.M.2    Kalyanaraman, B.3    Hallaway, P.E.4    Hedlund, B.E.5    Gross, G.J.6
  • 29
    • 0018394556 scopus 로고
    • Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent
    • DOI 10.1016/0014-5793(79)80111-8
    • Ponka, P., Borova, J., Neuwirt, J., and Fuchs, O. (1979) Mobilization of iron from reticulocytes. Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent FEBS Lett. 97, 317-321 (Pubitemid 9112866)
    • (1979) FEBS Letters , vol.97 , Issue.2 , pp. 317-321
    • Ponka, P.1    Borova, J.2    Neuwirt, J.3    Fuchs, O.4
  • 30
    • 0023780401 scopus 로고
    • Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes
    • Ponka, P., Richardson, D., Baker, E., Schulman, H. M., and Edward, J. T. (1988) Effect of pyridoxal isonicotinoyl hydrazone and other hydrazones on iron release from macrophages, reticulocytes and hepatocytes Biochim. Biophys. Acta 967, 122-129
    • (1988) Biochim. Biophys. Acta , vol.967 , pp. 122-129
    • Ponka, P.1    Richardson, D.2    Baker, E.3    Schulman, H.M.4    Edward, J.T.5
  • 32
    • 50249149460 scopus 로고    scopus 로고
    • Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone
    • Simunek, T., Sterba, M., Popelova, O., Kaiserova, H., Adamcova, M., Hroch, M., Haskova, P., Ponka, P., and Gersl, V. (2008) Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone Br. J. Pharmacol. 155, 138-148
    • (2008) Br. J. Pharmacol. , vol.155 , pp. 138-148
    • Simunek, T.1    Sterba, M.2    Popelova, O.3    Kaiserova, H.4    Adamcova, M.5    Hroch, M.6    Haskova, P.7    Ponka, P.8    Gersl, V.9
  • 33
    • 34248384887 scopus 로고    scopus 로고
    • Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH)
    • DOI 10.1016/j.tox.2007.03.020, PII S0300483X07001813
    • Sterba, M., Popelova, O., Simunek, T., Mazurova, Y., Potacova, A., Adamcova, M., Guncova, I., Kaiserova, H., Palicka, V., Ponka, P., and Gersl, V. (2007) Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH) Toxicology 235, 150-166 (Pubitemid 46734545)
    • (2007) Toxicology , vol.235 , Issue.3 , pp. 150-166
    • Sterba, M.1    Popelova, O.2    Simunek, T.3    Mazurova, Y.4    Potacova, A.5    Adamcova, M.6    Guncova, I.7    Kaiserova, H.8    Palicka, V.9    Ponka, P.10    Gersl, V.11
  • 34
    • 33745205646 scopus 로고    scopus 로고
    • Intralysosomal iron chelation protects against oxidative stress-induced cellular damage
    • Kurz, T., Gustafsson, B., and Brunk, U. T. (2006) Intralysosomal iron chelation protects against oxidative stress-induced cellular damage FEBS J. 273, 3106-3117
    • (2006) FEBS J. , vol.273 , pp. 3106-3117
    • Kurz, T.1    Gustafsson, B.2    Brunk, U.T.3
  • 36
    • 23944448097 scopus 로고    scopus 로고
    • Development of high-performance liquid chromatographic determination of salicylaldehyde isonicotinoyl hydrazone in rabbit plasma and application of this method to an in vivo study
    • DOI 10.1002/jssc.200500077
    • Kovarikova, P., Klimes, J., Sterba, M., Popelova, O., Mokry, M., Gersl, V., and Ponka, P. (2005) Development of high-performance liquid chromatographic determination of salicylaldehyde isonicotinoyl hydrazone in rabbit plasma and application of this method to an in vivo study J. Sep. Sci. 28, 1300-1306 (Pubitemid 41195339)
    • (2005) Journal of Separation Science , vol.28 , Issue.12 , pp. 1300-1306
    • Kovarikova, P.1    Klimes, J.2    Sterba, M.3    Popelova, O.4    Mokry, M.5    Gersl, V.6    Ponka, P.7
  • 37
    • 78249275855 scopus 로고    scopus 로고
    • BAY 11-7082, a nuclear factor-kappaB inhibitor, reduces inflammation and apoptosis in a rat cardiac ischemia-reperfusion injury model
    • Kim, Y. S., Kim, J. S., Kwon, J. S., Jeong, M. H., Cho, J. G., Park, J. C., Kang, J. C., and Ahn, Y. (2010) BAY 11-7082, a nuclear factor-kappaB inhibitor, reduces inflammation and apoptosis in a rat cardiac ischemia-reperfusion injury model Int. Heart J. 51, 348-353
    • (2010) Int. Heart J. , vol.51 , pp. 348-353
    • Kim, Y.S.1    Kim, J.S.2    Kwon, J.S.3    Jeong, M.H.4    Cho, J.G.5    Park, J.C.6    Kang, J.C.7    Ahn, Y.8
  • 38
    • 0034524377 scopus 로고    scopus 로고
    • In vivo models of myocardial ischemia and reperfusion injury: Application to drug discovery and evaluation
    • DOI 10.1016/S1056-8719(00)00102-7, PII S1056871900001027
    • Black, S. C. (2000) In vivo models of myocardial ischemia and reperfusion injury: application to drug discovery and evaluation J. Pharmacol. Toxicol. Methods 43, 153-167 (Pubitemid 32057037)
    • (2000) Journal of Pharmacological and Toxicological Methods , vol.43 , Issue.2 , pp. 153-167
    • Black, S.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.